FDA cannot prohibit the promotion of truthful, off-label uses

A federal judge has issued a preliminary injunction preventing the FDA from enforcing key regulations designed to prevent drug companies from promoting their products “off-label” uses, which have not been established as safe and effective by the agency. AboutLawsuits has more on the story here. Trial News adds that "Plaintiff attorneys are concerned about what this ruling means for consumer safety." Go here to read the full story.